TERM ID="NYU_TERM_1" STRING="Ad5" FREQUENCY=1 START=1209 END=1212 LEMMA="AD5" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="AdDeltaDelta" FREQUENCY=1 START=1043 END=1055 LEMMA="ADDELTADELTA" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="AdDeltaDelta mutant" FREQUENCY=2 START=1488 END=1507 LEMMA="ADDELTADELTA MUTANT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="AdDeltaDelta mutant" FREQUENCY=2 START=1750 END=1769 LEMMA="ADDELTADELTA MUTANT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_5" STRING="DeltaCR2 viruses" FREQUENCY=1 START=1217 END=1233 LEMMA="DELTACR2 VIRUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Mutants" FREQUENCY=1 START=747 END=754 LEMMA="MUTANT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_7" STRING="Optimisation" FREQUENCY=1 START=0 END=12 LEMMA="OPTIMISATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="Optimisation of replication-selective oncolytic adenoviral mutants" FREQUENCY=1 START=0 END=66 LEMMA="REPLICATION-SELECTIVE ONCOLYTIC ADENOVIRAL MUTANT OPTIMISATION" LEMMA_FREQUENCY=1 HEAD_TERM="Optimisation" HEAD_LEMMA="OPTIMISATION"
TERM ID="NYU_TERM_9" STRING="Replication" FREQUENCY=1 START=1169 END=1180 LEMMA="REPLICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="apoptosis" FREQUENCY=1 START=969 END=978 LEMMA="APOPTOSI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="cancer cell lines" FREQUENCY=1 START=1391 END=1408 LEMMA="CANCER CELL LINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="cellular mechanisms" FREQUENCY=1 START=460 END=479 LEMMA="CELLULAR MECHANISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="chemotherapeutics" FREQUENCY=1 START=356 END=373 LEMMA="CHEMOTHERAPEUTIC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="chemotherapeutics AdDeltaDelta synergistically enhanced cell death" FREQUENCY=1 START=1310 END=1376 LEMMA="CHEMOTHERAPEUTICS ADDELTADELTA SYNERGISTICALLY ENHANCED CELL DEATH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_15" STRING="chemotherapeutics Replication-selective oncolytic adenoviruses" FREQUENCY=1 START=87 END=149 LEMMA="CHEMOTHERAPEUTICS REPLICATION-SELECTIVE ONCOLYTIC ADENOVIRUS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_16" STRING="clinical efficacy" FREQUENCY=1 START=253 END=270 LEMMA="CLINICAL EFFICACY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="cytotoxic drugs" FREQUENCY=2 START=544 END=559 LEMMA="CYTOTOXIC DRUG" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_18" STRING="cytotoxic drugs" FREQUENCY=2 START=844 END=859 LEMMA="CYTOTOXIC DRUG" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_19" STRING="cytotoxic drugs including gemcitabine" FREQUENCY=1 START=844 END=881 LEMMA="INCLUDING GEMCITABINE CYTOTOXIC DRUG" LEMMA_FREQUENCY=1 HEAD_TERM="including gemcitabine" HEAD_LEMMA="INCLUDING GEMCITABINE"
TERM ID="NYU_TERM_20" STRING="cytotoxic factors" FREQUENCY=1 START=1587 END=1604 LEMMA="CYTOTOXIC FACTOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="docetaxel" FREQUENCY=1 START=906 END=915 LEMMA="DOCETAXEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="including gemcitabine" FREQUENCY=1 START=860 END=881 LEMMA="INCLUDING GEMCITABINE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="increase efficacy" FREQUENCY=1 START=386 END=403 LEMMA="INCREASE EFFICACY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="killing activity" FREQUENCY=1 START=1107 END=1123 LEMMA="KILLING ACTIVITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="mitoxantrone" FREQUENCY=1 START=920 END=932 LEMMA="MITOXANTRONE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="mutant" FREQUENCY=1 START=1086 END=1092 LEMMA="MUTANT" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_27" STRING="normal cells" FREQUENCY=1 START=1276 END=1288 LEMMA="NORMAL CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="novel adenoviral mutants" FREQUENCY=1 START=638 END=662 LEMMA="NOVEL ADENOVIRAL MUTANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="pancreatic carcinoma models" FREQUENCY=1 START=1140 END=1167 LEMMA="PANCREATIC CARCINOMA MODEL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="pancreatic xenografts" FREQUENCY=1 START=1429 END=1450 LEMMA="PANCREATIC XENOGRAFT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_31" STRING="promising anti-tumour therapeutic agents" FREQUENCY=1 START=154 END=194 LEMMA="PROMISING ANTI-TUMOUR THERAPEUTIC AGENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_32" STRING="prostate" FREQUENCY=2 START=1127 END=1135 LEMMA="PROSTATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_33" STRING="prostate" FREQUENCY=2 START=1416 END=1424 LEMMA="PROSTATE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_34" STRING="replication-selective oncolytic adenoviral mutants" FREQUENCY=1 START=16 END=66 LEMMA="REPLICATION-SELECTIVE ONCOLYTIC ADENOVIRAL MUTANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="sensitise normal cells" FREQUENCY=1 START=991 END=1013 LEMMA="SENSITISE NORMAL CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="toxic doses" FREQUENCY=1 START=1635 END=1646 LEMMA="TOXIC DOSE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="viral mutants" FREQUENCY=1 START=292 END=305 LEMMA="VIRAL MUTANT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="vivo" FREQUENCY=1 START=1454 END=1458 LEMMA="VIVO" LEMMA_FREQUENCY=1
